The Ferriman-Gallwey Score: How Hirsutism Is Actually Measured
7 min read
A registered dietitian and clinician review is being arranged for this site. Until this article carries a named reviewer, treat it as a well-sourced summary of published guidance — not as a substitute for advice about your own case.
The short answer
A Ferriman-Gallwey score grades coarse hair growth at nine body sites on a 0-to-4 scale, for a total of 0 to 36. A modified score of 8 or higher defines hirsutism in most white and Black populations studied, but that cutoff shifts by ethnicity and does not, by itself, diagnose PCOS.
What Is the Ferriman-Gallwey Score?
The Ferriman-Gallwey score rates coarse, pigmented terminal hair at nine body sites — upper lip, chin, chest, upper back, lower back, upper abdomen, lower abdomen, upper arms, and thighs — each scored from 0 (no terminal hair) to 4 (extensive growth), for a total that runs from 0 to 36.
A clinician assigns the number by comparing what they see against a set of standard reference photographs, one per site per severity level, published alongside the scale. David Ferriman and John Gallwey first described the method in 1961, scoring 11 body areas rather than nine. The version used today drops two of those sites, which is why almost everyone now means the same thing by “Ferriman-Gallwey score,” “modified Ferriman-Gallwey score,” and “mFG score.”
Note: in May 2026, PCOS was renamed polyendocrine metabolic ovarian syndrome, or PMOS, by a global consensus of more than 50 organisations. Same condition, same hyperandrogenism criteria — only the label changed. This article uses PCOS, since that is still the term most readers search.
What Does “Modified” Mean — Is mFG a Different Test?
No. The modified Ferriman-Gallwey (mFG) score is not a separate or newer instrument; it is the original scale with two of the 11 sites dropped — the forearms and lower legs. A 2010 review in Human Reproduction Update explains why: hair growth at those two sites tracks genetics and ethnic background far more than androgen exposure, so scoring them added noise rather than useful information. Removing them left the nine sites used today, and “Ferriman-Gallwey score,” “modified Ferriman-Gallwey,” and “mFG score” all now refer to that same nine-site version. If a clinician or a lab report mentions any of the three, they mean the same number.
What Score Actually Counts as Hirsutism?
An mFG score of 3 or higher marked a real jump in how women rated their own hair growth, in a 2006 study of 633 unselected Black and white American women attending a routine physical exam rather than a hirsutism clinic. At a score of 3 or above, 69.3% of women called themselves hirsute, compared with 15.8% below it — and the study found no meaningful difference in scores between Black and white participants.
That epidemiological inflection point is looser than the threshold clinicians actually use to flag hirsutism for a workup. The Endocrine Society’s clinical practice guideline sets the working cutoff nearer 8 for women of primarily European or African ancestry, recommends a lower threshold in East Asian women — who grow visibly less terminal hair at a given androgen level — and accepts a higher baseline as normal in women of Mediterranean, Middle Eastern, or South Asian descent. A number on a chart only means something once it is read against the population it came from.
| Population studied | Score typically used to flag hirsutism | What it means |
|---|---|---|
| Unselected Black and white US women (DeUgarte 2006) | ≥3 marked the top quartile; ≥8 matched self-identified hirsutism | Population-level inflection point, not a diagnostic cutoff on its own |
| European- or African-ancestry populations (Endocrine Society guideline) | ≥8 | The standard clinical cutoff used in most PCOS studies |
| East Asian populations | Lower than 8 | Guideline recommends adjusting down — less terminal hair grows at the same androgen level |
| Mediterranean, Middle Eastern, South Asian populations | Higher than 8 accepted as normal | Guideline recommends adjusting up — a higher baseline is not pathological here |
Why Isn’t a Ferriman-Gallwey Score a Self-Test?
mFG scoring is semi-quantitative and depends on a trained eye comparing hair against reference photographs. The same 2010 review found significant inter-observer variability even among clinicians using the identical scale, and noted that more objective methods — photographic densitometry, microscopic hair counts — exist but are too costly and complex for routine use. A mirror check at home substitutes a much less trained, much less consistent observer for the one the scale was built around. A number you assign yourself is not comparable to one your doctor assigns, and it is not the number that belongs in a diagnostic workup.
Who Shouldn’t Rely on a Ferriman-Gallwey Score Alone?
- Anyone who removes hair regularly — shaving, waxing, plucking, threading, laser, or electrolysis — before being scored. The scale measures hair that is visibly present, so recent removal drives the number down without changing the androgen signal underneath it. A clinician should ask about removal habits before scoring, but a self-reported history is not always complete.
- Anyone already on hormonal treatment that suppresses new hair formation. A lowered score in that case reflects treatment response, not baseline androgen status, and cannot retroactively rule PCOS in or out.
- Populations without a locally validated cutoff. The guideline’s regional adjustments cover the major groups studied so far, but a clinician working outside those categories is applying an approximation, not a validated number.
- Anyone with a low or borderline score and no other features. A normal mFG score does not rule out PCOS on its own — some phenotypes, including lean PCOS, can carry biochemical hyperandrogenism with little or no visible hair change.
What Happens After You Get a Ferriman-Gallwey Score?
A raised mFG score is one of three findings the 2023 international PCOS guideline weighs alongside irregular ovulation and polycystic ovarian morphology on ultrasound — meeting two of the three, after other causes are excluded, is what the Rotterdam criteria used across the rest of a PCOS work-up require. If you are wondering how the rest of that workup fits together, and why it rarely wraps up in a single visit, the process usually takes months, not one appointment. Some clinics also order a specialty urine hormone panel like the DUTCH test alongside or instead of standard bloodwork — it is worth knowing what that panel does and does not add before paying for it.
Once hirsutism is confirmed, the treatment question is separate from the measurement question — what actually reduces the hair itself, and how long each option takes to work, is covered in full there, and a direct comparison of removal methods sits in laser versus electrolysis versus eflornithine cream.
Common Questions
Common questions
What is a modified Ferriman-Gallwey (mFG) score?
It is the standard tool for rating visible hirsutism, scoring nine body sites from 0 to 4 for a total of 0 to 36. It is called "modified" because it dropped two of the 11 sites in the original 1961 scale — the forearms and lower legs — since hair there tracks ethnicity more than androgen exposure.What mFG score counts as hirsutism?
A score of 8 or higher is the standard clinical cutoff for women of European or African ancestry, per the Endocrine Society's guideline. The threshold is set lower for East Asian women and higher for women of Mediterranean, Middle Eastern, or South Asian descent, because normal hair growth varies by population.Can I score my own hirsutism at home?
Not reliably. Even trained clinicians using the same reference photographs show meaningful disagreement in study data, and recent shaving, waxing, or laser treatment lowers the score without changing the androgen levels driving it. A self-assessed number is not the one used in a diagnostic workup.Does a low Ferriman-Gallwey score rule out PCOS?
No. Some PCOS phenotypes, including lean PCOS, show elevated androgens on bloodwork with little or no visible excess hair. The mFG score is one of three Rotterdam criteria, not a standalone test, and a normal score does not exclude the other two.Does the score change once you start treatment?
Slowly. Hormonal treatments stop new terminal hair from forming but do not remove hair that has already converted, so a visible drop in score takes six months or longer and only tracks new growth, not the hair already present.Why does the same amount of hair get a different score depending on ethnicity?
Because the clinical cutoff is set relative to a population's baseline hair growth, not an absolute number. East Asian women grow visibly less terminal hair at a given androgen level, so guidelines use a lower cutoff; Mediterranean, Middle Eastern, and South Asian women have a higher normal baseline, so more hair is needed before the same score is considered abnormal.
- Are the 4 Types of PCOS Real? What the Phenotypes Actually AreThe '4 types of PCOS' online aren't a real diagnosis. Here's the actual Rotterdam A-D phenotype system doctors use, and what each label means.
- The DUTCH Test for PCOS: What It Measures and Whether It Changes TreatmentThe DUTCH test reads dried urine for hormone metabolites. What it actually measures, why no guideline recommends it for PCOS, and whether results change care.
- How Long a PCOS Diagnosis Takes — and Why the Average Is Over Two YearsOne-third of women wait over two years for a PCOS diagnosis. Why exclusion-based testing takes so long, what speeds it up, and who it fails most often.
- Is PMOS the Same as PCOS? Yes — Here Is Exactly What ChangedPMOS and PCOS are the same condition. A 2026 global consensus in The Lancet changed the name, not the diagnostic criteria, the biology, or the treatment.
Sources
- 1.DeUgarte CM, Woods KS, Bartolucci AA, Azziz R. Degree of Facial and Body Terminal Hair Growth in Unselected Black and White Women: Toward a Populational Definition of Hirsutism. J Clin Endocrinol Metab. 2006.
- 2.Yildiz BO, Bolour S, Woods K, Moore A, Azziz R. Visually Scoring Hirsutism. Hum Reprod Update. 2010.
- 3.Martin KA, Anderson RR, Chang RJ, et al. Evaluation and Treatment of Hirsutism in Premenopausal Women: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2018.
- 4.Teede HJ, Tay CT, Laven JJE, et al. Recommendations From the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome. J Clin Endocrinol Metab. 2023.
- 5.Teede HJ, Khomami MB, Morman R, et al. Polyendocrine metabolic ovarian syndrome, the new name for polycystic ovary syndrome: a multistep global consensus process. Lancet. 2026.